F2 Bioscience I 2017 Ltd - Insider Trading & Ownership

Entity
Company
Location
8, Rue Saint Leger, Geneva, Switzerland
Summary
The estimated value of insider holdings of F2 Bioscience I 2017 Ltd is at least $55.2M dollars as of June 23, 2022. F2 Bioscience I 2017 Ltd is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $55.2M.
All Insider Reports
All Insider Reports

Ownership of F2 Bioscience I 2017 Ltd

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $55.2M Jun 21, 2022

Insider Transactions Reported by F2 Bioscience I 2017 Ltd:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.